For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently ...

Patients assigned to SRT received an average of 10.7 doses of ranibizumab (Lucentis) over 2 years as compared with 13.3 for patients assigned to sham SRT. Best-corrected visual acuity (BCVA) did not ...

Precision-targeted radiation is proving a match for surgery in early-stage lung cancer, offering patients similar long-term survival with less invasiveness, and potentially transforming how this ...

Patritumab deruxtecan (HER3-DXd) in active brain metastases from metastatic breast and non-small cell lung cancers, and leptomeningeal disease from advanced solid tumors: The TUXEDO-3 phase II trial.

Preoperative stereotactic radiotherapy (SRT) was just as safe as postoperative SRT for patients with resectable brain metastases. More patients treated with preoperative SRT completed both radiation ...

Targeted treatments, including antibody-drug conjugates and immunotherapy agents, are now standard of care for breast cancer, but there are limited data on the safety of combining these newer agents ...

Cancer patients in Malta now have access to improved cancer treatment thanks to a new computed tomography (CT) scanner installed late last year at the country’s Sir Anthony Mamo Oncology Centre (SAMOC ...